Cargando…
Safety after BBIBP-CorV (Sinopharm) COVID-19 Vaccine in Adolescents Aged 10–17 Years in Thailand
Coronavirus disease 2019 affected child health and impacted learning because of the resulting onsite school closures. This prospective cohort study included children aged 10–17 who received two 4 µg doses of BBIBP-CorV administered intramuscularly 21–28 days apart. To assess vaccine safety, 36,808 p...
Autores principales: | Thonginnetra, Saraiorn, Tawinprai, Kriangkrai, Niemsorn, Krongkwan, Promsena, Pathariya, Tandhansakul, Manunya, Kasemlawan, Naruporn, Ruangkijpaisal, Natthanan, Banomyong, Narin, Phattraprayoon, Nanthida, Rangkakulnuwat, Pisuttikan, Vanichsetakul, Preeda, Ungtrakul, Teerapat, Wittayasak, Kasiruck, Thonwirak, Nawarat, Soonklang, Kamonwan, Mahanonda, Nithi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612063/ https://www.ncbi.nlm.nih.gov/pubmed/36298630 http://dx.doi.org/10.3390/vaccines10101765 |
Ejemplares similares
-
Safety and Immunogenicity of the BBIBP-CorV Vaccine in Adolescents Aged 12 to 17 Years in the Thai Population: An Immunobridging Study
por: Tawinprai, Kriangkrai, et al.
Publicado: (2022) -
SARS-CoV-2 seroprevalence among cancer patients and household caregivers in a cancer hospital: Cross-sectional survey after the second COVID-19 wave in Thailand
por: Ungtrakul, Teerapat, et al.
Publicado: (2022) -
Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received two doses of CoronaVac: A randomized controlled trial
por: Tawinprai, Kriangkrai, et al.
Publicado: (2022) -
Supporting factors and structural barriers in the continuity of breastfeeding in the hospital workplace
por: Jiravisitkul, Paveewan, et al.
Publicado: (2022) -
Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines
por: Cohen, Guy, et al.
Publicado: (2022)